A model for amyloid fibril formation in immunoglobulin light chains based on comparison of amyloidogenic and benign proteins and specific antibody binding

References

• Cohen A S, Jones L A. Amyloidosis. Curr Opin Rheumatol 1991; 3: 125–138
   PubMedGoogle Scholar
• Sipe J D. Amyloidosis. Crit Rev Clin Lab Sci 1994; 31: 325–54
   PubMed Web of Science ®Google Scholar
• Buxbaum J N, Chuba J V, Hellman G C, Solomon A, Gallo G R. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 1990; 112: 455–64
   PubMed Web of Science ®Google Scholar
• Stevens F J, Solomon A, Schiffer M. Bence Jones proteins: a powerful tool for the fundamental study of protein chemistry and pathophysiology. Biochemistry 1991; 30: 6803–5
   PubMed Web of Science ®Google Scholar
• Davis D P, Gallo G, Vogen S M, Dul J L, Sciarretta K L, Kumar A, Raffen R, Stevens F J, Argon Y. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain. J Mol Biol 2001; 313: 1021–1034
   PubMed Web of Science ®Google Scholar
• Bellotti V, Merlini G. Current concepts on the pathogenesis of systemic amyloidosis. Nephrol Dial Transplant 1996; 11(Suppl 9)53–62
   PubMed Web of Science ®Google Scholar
• Hurle M R, Helms L R, Li L, Chan W, Wetzel R. A role for destabilizing amino acid replacements in light‐chain amyloidosis. Proc Natl Acad Sci USA 1994; 91: 5446–50
   PubMed Web of Science ®Google Scholar
• Stevens F J, Myatt E A, Chang C H, Westholm F A, Eulitz M, Weiss D T, Murphy C, Solomon A, Schiffer M. A molecular model for self‐assembly of amyloid fibrils: immunoglobulin light chains. Biochemistry 1995; 34: 10697–702
   PubMed Web of Science ®Google Scholar
• Kim Y, Wall J S, Meyer J, Murphy C, Randolph T W, Manning M C, Solomon A, Carpenter J F. Thermodynamic modulation of light chain amyloid fibril formation. J Biol Chem 2000; 275: 1570–1574
   PubMed Web of Science ®Google Scholar
• Merlini G, Bellotti V, Andreola A, Palladini G, Obici L, Casarini S, Perfetti V. Protein aggregation. Clin Chem Lab Med 2001; 39: 1065–1075
   PubMed Web of Science ®Google Scholar
• Pras M, Schubert M, Zucker‐Franklin D, Rimon A, Franklin E C. The characterization of soluble amyloid prepared in water. J Clin Invest 1968; 47: 924–33
   PubMed Web of Science ®Google Scholar
• Solomon A. Light chains of human immunoglobulins. Methods Enzymol 1985; 116: 101–21
   PubMed Web of Science ®Google Scholar
• Raffen R, Dieckman L J, Szpunar M, Wunschl C, Pokkuluri P R, Dave P, Wilkins S P, Cai X, Schiffer M, Stevens F J. Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains. Protein Sci 1999; 8: 509–517
   PubMed Web of Science ®Google Scholar
• Huang D B, Chang C H, Ainsworth C, Johnson G, Solomon A, Stevens F J, Schiffer M. Variable domain structure of kappalV human light chain Len: high homology to the murine light chain McPC603. Mol. Immunol 1997; 34: 1291–1301
   PubMed Web of Science ®Google Scholar
• Khurana R, Gillespie J R, Talapatra A, Minert L J, Ionescu‐Zanetti C, Millett I, Fink A L. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 2001; 40: 3525–3535
   PubMed Web of Science ®Google Scholar
• Souillac P O, Uversky V N, Millett I S, Khurana R, Doniach S, Fink A L. Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation: Evidence for an off‐pathway oligomer at acidic pH. J. Biol Chem 2002; 277: 12657–12665
   PubMed Web of Science ®Google Scholar
• Souillac P O, Uversky V N, Millett I S, Khurana R, Doniach S, Fink A L. Effect of association state and con‐formational stability on the kinetics of immunoglobulin light chain amyloid fibril formation at physiological pH. J Biol Chem 2002; 277: 12657–12665
   PubMed Web of Science ®Google Scholar
• Stevens P W, Raffen R, Hanson D K, Deng Y L, Berrios‐Hammond M, Westholm F A, Murphy C, Eulitz M, Wetzel R, Solomon A, Schiffer M, Stevens F J. Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light‐chain amyloid proteins. Protein Sci 1995; 4: 421–432
   PubMed Web of Science ®Google Scholar
• Khurana R, Hate A T, Nath U, Udgaonkar J B. pH dependence of the stability of barstar to chemical and thermal denaturation. Protein Sci 1995; 4: 1133–1144
   PubMed Web of Science ®Google Scholar
• Oberg K A, Fink A L. Methods for Collecting and Analyzing Attenuated Total Reflectance FTIR Spectra of Proteins in Solution. Techniques in Protein Chemistry, W Crabb. Academic Press, Inc. 1995; 475–484
   Google Scholar
• Oberg K A, Fink A L. A new attenuated total reflectance Fourier transform infrared spectroscopy method for the study of proteins in solution. Anal Biochem 1998; 256: 92–106
   PubMed Web of Science ®Google Scholar
• Seshadri S, Khurana R, Fink A L. FTIR Analysis of Protein Deposits. Methods in Enzymology 1999; 309: 559–576
   PubMed Web of Science ®Google Scholar
• Naiki H, Higuchi K, Hosokawa M, Takeda T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem 1989; 177: 244–249
   PubMed Web of Science ®Google Scholar
• Levine H. Thioflavine‐T Interaction with Synthetic Alzheimers Disease β‐Amyloid Peptides ‐ Detection of Amyloid Aggregation in Solution. Protein Science 1993; 2: 404–410
   PubMed Web of Science ®Google Scholar
• Abe M, Goto T, Wolfenbarger D, Weiss D T, Solomon A. Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable‐region subgroups. Hybridoma 1993; 12: 475–483
   PubMedGoogle Scholar
• Fink A L. Compact intermediate states in protein folding. Annu Rev Biophys Biomol Struct 1995; 24: 495–522
   PubMedGoogle Scholar
• Semisotnov G V, Rodionova N A, Razgulyaev O I, Uversky V N, Gripas' A F, Gilmanshin R I. Study of the “molten globule” intermediate state in protein folding by a hydrophobic fluorescent probe. Biopolymers 1991; 31: 119–28
   PubMed Web of Science ®Google Scholar
• Goto Y, Fink A L. Conformational states of beta‐lactamase: molten‐globule states at acidic and alkaline pH with high salt. Biochemistry 1989; 28: 945–52
   PubMed Web of Science ®Google Scholar
• Zaremba S M, Gregoret L M. Context‐dependence of amino acid residue pairing in antiparallel beta‐sheets. J Mol Biol 1999; 291: 463–479
   PubMed Web of Science ®Google Scholar
• Fink A L, Calciano L J, Goto Y, Kurotsu T, Palleros D R. Classification of acid denaturation of proteins ‐ intermediates and unfolded states. Biochemistry 1994; 33: 12504–12511
   PubMed Web of Science ®Google Scholar
• Ionescu‐Zanetti C, Khurana R, Gillespie J R, Petrick J S, Trabachino L C, Minert L J, Carter S A, Fink A L. Monitoring the assembly of Ig light‐chain amyloid fibrils by atomic force microscopy. Proc Natl Acad Sci USA 1999; 96: 13175–13179
   PubMed Web of Science ®Google Scholar
• Hmcic R, Wall J, Wolfenbarger D A, Murphy C L, Schell M, Weiss D T, Solomon A. Antibody‐mediated resolution of light chain‐associated amyloid deposits. Am J Pathol 2000; 157: 1239–1246
   PubMed Web of Science ®Google Scholar
• Gillespie J R, Shortle D. Characterization of Long‐Range Structure in the Denatured State of Staphylococcal Nuclease 1. Paramagnetic Relaxation Enhancement by Nitroxide Spin Labels. J Mol Biol 1997; 268: 158–169
   PubMed Web of Science ®Google Scholar
• Wang and Shortle. Residual helical and turn structure in the denatured state of staphylococcal nuclease: analysis of peptide fragments. Folding & Design 1997; 2: 93–100
   PubMedGoogle Scholar
• Yao J, Chung J, Eliezer D, Wright P E, Dyson H J. NMR structural and dynamic characterization of the acid‐unfolded state of apomyoglobin provides insights into the early events in protein folding. Biochemistry 2001; 40: 3561–3571
   PubMed Web of Science ®Google Scholar
• Eliezer D, Chung J, Dyson H J, Wright P E. Native and non‐native secondary structure and dynamics in the pH 4 intermediate of apomyoglobin. Biochemistry 2000; 39: 2894–2901
   PubMed Web of Science ®Google Scholar
• Liu Y, Gotte G, Libonati M, Eisenberg D. A domain‐swapped RNase A dimer with implications for amyloid formation. Nat Struct Biol 2001; 8: 211–214
   PubMedGoogle Scholar
• Liu Y, Hart P J, Schlunegger M P, Eisenberg D. The crystal structure of a 3D domain‐swapped dimer of RNase A at a 2.1‐A resolution. Proc Natl Acad Sci USA 1998; 95: 3437–3442
   PubMed Web of Science ®Google Scholar
• Davis P D, Raffen R, Dul L J, Vogen M S, Williamson K E, Stevens J F, Argon Y. Inhibition of amyloid fiber assembly by both BiP and its target peptide. Immunity 2000; 13: 433–442
   PubMed Web of Science ®Google Scholar
• Huang D B, Chang C H, Ainsworth C, Johnson G, Solomon A, Stevens F J, Schiffer M. Variable domain structure of kappaIV human light chain Len: high. Mol Immunol 1997; 34: 1291–301
   PubMed Web of Science ®Google Scholar